ConductScience.org, home

Paper8515422

Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.

Ware DC and 3 others. J Med Chem, 1993. Cited by 112 papers, by iCite.

Cite this record

ConductScience Library. Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards. Papers, record 8515422. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8515422

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.
PubMed
Journal
J Med Chem
PubMed
Year
1993
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
112
iCite
Relative citation ratio, by iCite
3.6
iCite
Revised in PubMed
2019-07-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ware DCD C
2Palmer BDB D
3Wilson WRW R
4Denny WAW A

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
CobaltMajor topic
Nitrogen Mustard CompoundsMajor topic
Animals
CHO Cells
Cell Hypoxia
Cricetinae
Cricetulus
Drug Screening Assays, Antitumor
Oxidation-Reduction
Structure-Activity Relationship

Source PubMed

Download CSV of topics

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 112 citations.

PMIDTitleJournalYearIn PapersSource
42432465Medicinal Chemistry of Agents for Cancer Therapy and Diagnosis From Uruguay.ChemMedChem2026https://conductscience.org/library/papers/42432465PubMed
41574478Tumor-Selective and Chemical Activation Strategies for Nitrogen Mustard Prodrugs.Chemistry2026https://conductscience.org/library/papers/41574478PubMed
34046181Development of a cobalt(iii)-based ponatinib prodrug system.Inorg Chem Front2021https://conductscience.org/library/papers/34046181PubMed
33222438Improving the Stability of EGFR Inhibitor Cobalt(III) Prodrugs.Inorg Chem2020https://conductscience.org/library/papers/33222438PubMed
30672949Physical properties, ligand substitution reactions, and biological activity of Co(iii)-Schiff base complexes.Dalton Trans2019https://conductscience.org/library/papers/30672949PubMed
30575832Hypoxia-targeted drug delivery.Chem Soc Rev2019https://conductscience.org/library/papers/30575832PubMed
29259746Synthesis and Evaluation of Radiolabeled Phosphoramide Mustard with Selectivity for Hypoxic Cancer Cells.ACS Med Chem Lett2017https://conductscience.org/library/papers/29259746PubMed
27143654Hypoxic tumor microenvironment: Opportunities to develop targeted therapies.Biotechnol Adv2016https://conductscience.org/library/papers/27143654PubMed
25079700Tumor-targeting of EGFR inhibitors by hypoxia-mediated activation.Angew Chem Int Ed Engl2014https://conductscience.org/library/papers/25079700PubMed
23845143Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia.Chin J Cancer2014https://conductscience.org/library/papers/23845143PubMed
23001051Synthesis, characterization, and antibacterial and anticancer screening of {M(2+)-Co (3+)-M (2+)} and {Co (3+)-M (2+)} (M is Zn, Cd, Hg) heterometallic complexes.J Biol Inorg Chem2012https://conductscience.org/library/papers/23001051PubMed
22289471Redox activation of metal-based prodrugs as a strategy for drug delivery.Adv Drug Deliv Rev2012https://conductscience.org/library/papers/22289471PubMed
21606941Targeting hypoxia in cancer therapy.Nat Rev Cancer2011https://conductscience.org/library/papers/21606941PubMed
21275772Anticancer activity of metal complexes: involvement of redox processes.Antioxid Redox Signal2011https://conductscience.org/library/papers/21275772PubMed
19772288In situ imaging of metals in cells and tissues.Chem Rev2009https://conductscience.org/library/papers/19772288PubMed
18418632Cellular uptake and distribution of cobalt complexes of fluorescent ligands.J Biol Inorg Chem2008https://conductscience.org/library/papers/18418632PubMed
10815768Cyclophosphamides as hypoxia-activated diffusible cytotoxins: a theoretical study.J Comput Aided Mol Des2000https://conductscience.org/library/papers/10815768PubMed
8763845Pulse radiolysis studies on the hypoxia-selective toxicity of a colbalt-mustard complex.Br J Cancer Suppl1996https://conductscience.org/library/papers/8763845PubMed
8763842Recent developments in the design of bioreductive drugs.Br J Cancer Suppl1996https://conductscience.org/library/papers/8763842PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8515422

GET https://conductscience.org/api/papers/v1/8515422/authors